Sintx Technologies

SINT on Nasdaq. Market value $10m.

Watch this stockFree. We tell you when something changes.

Should I look at this?

Look carefully before going further

Why it could be worth it

Nothing stands out yet.

Read the warning sign in its own filings

This is not advice.

Compare with another stock

Who owns it

None of the long-term investors we follow own it. 20 funds in all.

Jun '25
Dec '25
Jun '26
Largest holders overall

From 13F filings for the quarter ended 30 June 2026.

Big holders and activists

11 investors own more than 5%.

  • Bleichroeder LP
    Passive investor
    at least 10.0%
    (filed with 2 related holders)
    Since 30 June 2026
  • LYTTON LAURENCE W
    Passive investor
    10.0%
    Since 3 June 2026
  • MEDTECH CERAMICS, LP
    Passive investor
    9.9%
    Since 26 February 2025
  • at least 8.2%−1.7 pts
    (filed with 3 related holders)
    Since 30 September 2026
  • Kevin Patrick Murphy
    Passive investor
    8.2%
    Since 29 August 2025
  • Sinaptic Surgical, LLC
    Passive investor
    7.9%
    Since 1 July 2025
  • Lawrence W. Lytton
    Passive investor
    at least 7.4%−2.6 pts
    (filed with 1 related holder)
    Since 30 September 2026
  • Sinaptic Holdings, LLC
    Passive investor
    7.2%−0.7 pts
    Since 10 July 2025
  • 5.3%
    Since 25 September 2025
  • Gregg Richard Honigblum
    Passive investor
    5.0%
    Since 8 December 2025
  • Lind Global Fund II LP
    Passive investor
    at least 2.8%−2.4 pts
    (filed with 2 related holders)
    Since 31 March 2025
  • L1 Capital Global Opportunities Master Fund, Ltd.
    Passive investor
    Sold down below 5%
    Since 31 December 2024

From Schedule 13D and 13G filings: anyone owning more than 5% must file one.

What insiders did

In the last 12 months, 4 insiders bought $326,308 of shares on the open market.

  • Lyons Christopher Michael
    Director
    Bought
    Date
    2 March 2026
    Shares
    7,534
    Price
    $2.90
    Value
    $21,849
  • Lyons Christopher Michael
    Director
    Bought
    Date
    25 February 2026
    Shares
    758
    Price
    $2.96
    Value
    $2,244
  • MOYES JAY M
    Director
    Bought
    Date
    23 February 2026
    Shares
    1,000
    Price
    $2.91
    Value
    $2,910
  • Anderson Mark Lewis
    Director
    Bought
    Date
    18 February 2026
    Shares
    3,000
    Price
    $3.02
    Value
    $9,060
  • Honigblum Gregg R.
    Chief Investment Officer, Director
    Bought
    Date
    8 December 2025
    Shares
    8,200
    Price
    $4.26
    Value
    $34,896
  • Honigblum Gregg R.
    Chief Investment Officer, Director
    Bought
    Date
    5 December 2025
    Shares
    65,000
    Price
    $3.93
    Value
    $255,350

From Form 4 filings: insiders must report trades in their own company's shares within two days.

Warning signs in its filings

Problems the company itself reported to the SEC, in its own words.

1 serious warning sign in Sintx Technologies’ filings.

We look for five warning signs: doubt it can keep going, weak checks on its own accounts, a notice that its past accounts can't be relied on, a change of auditor, and one customer bringing in a big share of sales. We don't check lawsuits, investigations or debt yet.

We checked the auditor's report, internal controls, restatement notices, auditor changes and big customers in the 10-K filed 20 Mar 2026, plus the 10-Q filed 5 Nov 2026 and 9 later 8-Ks.

  • Doubt it can keep going

    Serious

    The company or its auditor warned it may not have enough money to last the next year.

    “Despite the actions undertaken by management to improve liquidity and operating costs—including increased commercial activity, cost and pricing improvement initiatives, commercialization of newly cleared medical products, equity financing activities, proceeds from warrant exercises subsequent to quarter-end, and other working capital initiatives—management has concluded that substantial doubt remains regarding our ability to continue as a going concern for a period of one year from the date these condensed consolidated financial statements are issued.”
    Show the full paragraph
    Despite the actions undertaken by management to improve liquidity and operating costs—including increased commercial activity, cost and pricing improvement initiatives, commercialization of newly cleared medical products, equity financing activities, proceeds from warrant exercises subsequent to quarter-end, and other working capital initiatives—management has concluded that substantial doubt remains regarding our ability to continue as a going concern for a period of one year from the date these condensed consolidated financial statements are issued. Our ability to continue as a going concern will depend on our ability to generate increased revenues and operating cash flows, manage expenditures, obtain additional financing, and successfully execute our strategic business objectives. The condensed consolidated financial statements do not include any adjustments that might result from the outcome of these uncertainties.

    From the 10-Q filed 5 November 2026, Part I, Item 2. Management's Discussion and Analysis. Read it in the filing

A 10-K is the yearly report every US company files with the SEC. An 8-K is a short notice of a big event.

The deep dive

Everything above is arithmetic on public filings. The deep dive reads the last ten years of annual reports, the proxy statements, and the earnings calls, then argues the case the way Buffett, Klarman, and Hohn would, and checks every claim against the source.

  • What the business is worth, as a range, and the margin of safety at today’s price
  • Prices to start buying, buy, and buy hard
  • The three things that would make this a mistake
  • Every number footnoted to the filing it came from
Create a free account to run it

Your first deep dive is free.

What a finished deep dive looks like

Not advice. Numbers on this page come from SEC filings and are updated each night; prices are updated again after the US market closes. The five-year figures are rounded.